MDSCs are known to suppress the functions of CD8+ T cells in the tumour microenvironment (TME) [24] and have received extensive research interest in recent years along with tumour-associated macrophages, neutrophils, and regulatory T cells [25, 26]. The gene discussed is CD8A; the disease is neoplasm.